Schedules of Nab-Paclitaxel in Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breastcancer
Interventions: DRUG: nab-Paclitaxel
Sponsor: ETOP IBCSG Partners Foundation
Collaborators: Breast International Group